Filing Flows › Thermo Fisher Scientific (TMO) › Life Sciences Solutions revenue
Thermo Fisher Scientific (TMO) Life Sciences Solutions revenue by quarter
Thermo Fisher Scientific's Life Sciences Solutions revenue was $2.3B in Q3 2026 (third quarter 2026), -3% from Q2 2026. Over the last 7 quarters it ranged from $2.0B (Q1 2025) to $2.5B (Q4 2025).
| Quarter | Life Sciences Solutions revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $2.3B | -3% | +4% |
| Q2 2026 | $2.4B | +6% | +11% |
| Q1 2026 | $2.2B | -12% | +14% |
| Q4 2025 | $2.5B | +15% | — |
| Q3 2025 | $2.2B | +4% | — |
| Q2 2025 | $2.1B | +8% | — |
| Q1 2025 | $2.0B | — | — |
Q3 2026 at a glance
Thermo Fisher Scientific, Q3 2026: revenue $12.1B (+9% year over year), operating margin 18.6%, net earnings $1.7B, operating cash flow $2.5B. The chart follows the revenue to costs, profit and cash.
Questions
What is Thermo Fisher Scientific's Life Sciences Solutions revenue?
Thermo Fisher Scientific's Life Sciences Solutions revenue was $2.3B in Q3 2026 (third quarter 2026), -3% from Q2 2026.
How has Thermo Fisher Scientific's Life Sciences Solutions revenue changed?
Over the last 7 quarters it ranged from $2.0B (Q1 2025) to $2.5B (Q4 2025).
Q3 2026 results → · How Thermo Fisher Scientific makes money →